EMulate Therapeutics, which is developing a non-invasive medical device that uses radio frequency energy, withdrew its plans for an initial public offering on Wednesday. It had most recently planned to raise $12 million by offering 2.3 million shares at a price...read more
EMulate Therapeutics, which is developing a non-invasive medical device that uses radio frequency energy, lowered the proposed deal size for its upcoming IPO on Wednesday. The Bellevue, WA-based company now plans to raise $12 million by offering 2.3 million...read more
EMulate Therapeutics, which is developing a non-invasive medical device that uses radio frequency energy, announced terms for its IPO on Wednesday. The Bellevue, WA-based company plans to raise $13 million by offering 2.5 million shares at a price range of $4...read more
Three small issuers began trading in another quiet week for the IPO market, though just two met our tracking criteria. In the pipeline, two IPOs submitted initial filings. The most notable news from the pipeline, AIG carve-out ...read more
Medical device developer EMulate Therapeutics withdraws $12 million IPO
EMulate Therapeutics, which is developing a non-invasive medical device that uses radio frequency energy, withdrew its plans for an initial public offering on Wednesday. It had most recently planned to raise $12 million by offering 2.3 million shares at a price...read more
Medical device developer EMulate Therapeutics lowers deal size by 8% ahead of $12 million IPO
EMulate Therapeutics, which is developing a non-invasive medical device that uses radio frequency energy, lowered the proposed deal size for its upcoming IPO on Wednesday. The Bellevue, WA-based company now plans to raise $12 million by offering 2.3 million...read more
Medical device developer EMulate Therapeutics sets terms for $13 million IPO
EMulate Therapeutics, which is developing a non-invasive medical device that uses radio frequency energy, announced terms for its IPO on Wednesday. The Bellevue, WA-based company plans to raise $13 million by offering 2.5 million shares at a price range of $4...read more
US IPO Weekly Recap: IPO market’s quiet August continues with a few small deals
Three small issuers began trading in another quiet week for the IPO market, though just two met our tracking criteria. In the pipeline, two IPOs submitted initial filings. The most notable news from the pipeline, AIG carve-out ...read more